MicroRNA Expression Signature for Predicting Survival and Metastases in Hepatocellular Carcinoma (miR-207, miR-219, miR-30c,miR-124a)
Switzerland
07867402.5
Filed on 2007-11-01
07867402.5
Filed on 2007-11-01
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
Italy
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
United Kingdom
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
France
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY
Switzerland
09763590.8
Filed on 2009-06-11
09763590.8
Filed on 2009-06-11
METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE
Italy
08768266.2
Filed on 2008-06-09
08768266.2
Filed on 2008-06-09
METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE
United Kingdom
08768266.2
Filed on 2008-06-09
08768266.2
Filed on 2008-06-09
METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE
France
08768266.2
Filed on 2008-06-09
08768266.2
Filed on 2008-06-09
METHODS FOR DETERMINING HEPATOCELLULAR CARCINOMA SUBTYPE
Spain
08768266.2
Filed on 2008-06-09
08768266.2
Filed on 2008-06-09
Methods for determining a hepatocellular carcinoma subtype
United Kingdom
12179592.6
Filed on 2008-06-09
12179592.6
Filed on 2008-06-09